Fast Market Research

Braasch Biotech LLC - Product Pipeline Review - 2013 - New Report Available

Recently published research from Global Markets Direct, "Braasch Biotech LLC - Product Pipeline Review - 2013", is now available at Fast Market Research


Boston, MA -- (SBWIRE) -- 02/11/2014 -- Global Market Direct's pharmaceuticals report, "Braasch Biotech LLC - Product Pipeline Review - 2013" provides data on the Braasch Biotech LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Braasch Biotech LLC's corporate website, SEC filings, investor presentations and featured press releases, both from Braasch Biotech LLC and industry-specific third party sources, put together by Global Markets Direct's team.


- Braasch Biotech LLC - Brief Braasch Biotech LLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Braasch Biotech LLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Braasch Biotech LLC with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Braasch Biotech LLC's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Braasch Biotech LLC's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Braasch Biotech LLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Braasch Biotech LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Braasch Biotech LLC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Braasch Biotech LLC and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- SWITCH Biotech LLC - Product Pipeline Review - 2013
- MedImmune, LLC - Product Pipeline Review - 2013
- Growth Hormone Deficiency - Pipeline Review, H2 2013
- Bharat Biotech International Limited - Product Pipeline Review - 2013
- Aduro BioTech, Inc. - Product Pipeline Review - 2013
- ReGenX Biosciences, LLC - Product Pipeline Review - 2013
- Deciphera Pharmaceuticals, LLC - Product Pipeline Review - 2013
- Digna Biotech, S.L. - Product Pipeline Review - 2013
- Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2013
- Oncolytics Biotech Inc. - Product Pipeline Review - 2013